K. Gorcyca

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.

A. Maggioni, M. Arca, A. Catapano, 2018, Atherosclerosis.

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.

Dylan L. Steen, J. Ferrières, D. Ansell, 2018, Clinical therapeutics.

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.

W. März, D. Ansell, K. Theobald, 2018, Atherosclerosis.

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.

S. Yamashita, H. Arai, T. Teramoto, 2016, Atherosclerosis.

Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed‐care population

Dylan L. Steen, R. Giugliano, J. Foody, 2017, Clinical cardiology.

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.

S. Yamashita, H. Arai, T. Teramoto, 2016, Atherosclerosis.